Cerity Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $451M | Buy |
1,846,524
+39,639
| +2% | +$9.23M | 0.64% | 25 |
|
|
2025
Q4 | $374M | Buy |
1,806,885
+24,241
| +1% | +$4.79M | 0.55% | 30 |
|
|
2025
Q3 | $331M | Sell |
1,782,644
-28,920
| -2% | -$4.95M | 0.54% | 29 |
|
|
2025
Q2 | $277M | Buy |
1,811,564
+39,452
| +2% | +$6.06M | 0.49% | 31 |
|
|
2025
Q1 | $294M | Buy |
1,772,112
+332,145
| +23% | +$52M | 0.6% | 27 |
|
|
2024
Q4 | $211M | Sell |
1,439,967
-19,113
| -1% | -$2.96M | 0.46% | 38 |
|
|
2024
Q3 | $236M | Buy |
1,459,080
+132,189
| +10% | +$21.1M | 0.52% | 33 |
|
|
2024
Q2 | $194M | Sell |
1,326,891
-38,018
| -3% | -$5.65M | 0.51% | 36 |
|
|
2024
Q1 | $214M | Sell |
1,364,909
-234,310
| -15% | -$37.3M | 0.57% | 30 |
|
|
2023
Q4 | $187M | Buy |
1,599,219
+688,955
| +76% | +$106M | 0.61% | 28 |
|
|
2023
Q3 | $142M | Sell |
910,264
-195,402
| -18% | -$32.2M | 0.69% | 30 |
|
|
2023
Q2 | $183M | Buy |
1,105,666
+154,730
| +16% | +$25M | 0.71% | 24 |
|
|
2023
Q1 | $1.7B | Buy |
950,936
+132,117
| +16% | +$21.3M | 4.01% | 6 |
|
|
2022
Q4 | $149M | Buy |
818,819
+317,711
| +63% | +$54.9M | 0.96% | 15 |
|
|
2022
Q3 | $81.9M | Sell |
501,108
-300
| -0.1% | -$50.8K | 0.98% | 13 |
|
|
2022
Q2 | $89M | Buy |
501,408
+208,836
| +71% | +$37.2M | 0.98% | 12 |
|
|
2022
Q1 | $49.4M | Sell |
292,572
-74,761
| -20% | -$12.7M | 0.77% | 22 |
|
|
2021
Q4 | $60.6M | Buy |
367,333
+125,355
| +52% | +$20.5M | 0.92% | 20 |
|
|
2021
Q3 | $39.1M | Sell |
241,978
-3,848
| -2% | -$656K | 0.86% | 19 |
|
|
2021
Q2 | $40.5M | Sell |
245,826
-1,699
| -0.7% | -$281K | 0.89% | 20 |
|
|
2021
Q1 | $40.7M | Buy |
247,525
+129,212
| +109% | +$20.9M | 0.97% | 18 |
|
|
2020
Q4 | $18.6M | Buy |
118,313
+6,898
| +6% | +$1.02M | 0.6% | 35 |
|
|
2020
Q3 | $16.6M | Buy |
111,415
+39,587
| +55% | +$5.86M | 0.68% | 25 |
|
|
2020
Q2 | $10.1M | Sell |
71,828
-3,779
| -5% | -$551K | 0.56% | 35 |
|
|
2020
Q1 | $9.91M | Sell |
75,607
-1,017
| -1% | -$144K | 0.62% | 28 |
|
|
2019
Q4 | $11.2M | Buy |
76,624
+2,875
| +4% | +$390K | 0.57% | 32 |
|
|
2019
Q3 | $9.54M | Buy |
73,749
+7,467
| +11% | +$984K | 0.56% | 42 |
|
|
2019
Q2 | $9.23M | Sell |
66,282
-3,512
| -5% | -$486K | 0.58% | 38 |
|
|
2019
Q1 | $9.76M | Sell |
69,794
-5,533
| -7% | -$741K | 0.66% | 30 |
|
|
2018
Q4 | $9.72M | Sell |
75,327
-112
| -0.1% | -$15.6K | 0.65% | 29 |
|
|
2018
Q3 | $10.4M | Sell |
75,439
-407
| -0.5% | -$54.1K | 0.72% | 27 |
|
|
2018
Q2 | $9.2M | Buy |
75,846
+1,687
| +2% | +$210K | 0.68% | 28 |
|
|
2018
Q1 | $9.5M | Sell |
74,159
-3,228
| -4% | -$436K | 0.73% | 25 |
|
|
2017
Q4 | $10.8M | Sell |
77,387
-458
| -0.6% | -$63.8K | 0.73% | 25 |
|
|
2017
Q3 | $10.1M | Buy |
77,845
+6,566
| +9% | +$870K | 0.72% | 26 |
|
|
2017
Q2 | $9.47M | Buy |
71,279
+5,810
| +9% | +$741K | 0.79% | 21 |
|
|
2017
Q1 | $8.15M | Buy |
65,469
+62,967
| +2,517% | +$7.52M | 0.68% | 22 |
|
|
2016
Q4 | $288K | Buy |
+2,502
| New | +$289K | 0.4% | 42 |
|
Other funds holding JNJ
VCM
VPM
Cerity Partners's JNJ Position: Q1 2026 in Review
Cerity Partners increased its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, buying an estimated $9.23M and bringing the position to 1,846,524 shares worth $451M. The position accounts for 0.64% of the portfolio, ranked #25.
Cerity Partners first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.7B in Q1 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Cerity Partners held 1,846,524 shares of Johnson & Johnson worth $451M as of Q1 2026.
- Cerity Partners bought 39,639 Johnson & Johnson shares in Q1 2026, an estimated $9.23M.
- Johnson & Johnson made up 0.64% of Cerity Partners's portfolio in Q1 2026, its #25 holding.
- Cerity Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
- Cerity Partners's Johnson & Johnson position peaked at $1.7B in Q1 2023.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.